These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 8384086)

  • 1. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
    Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S
    Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2 (PGE2) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4.
    Conti P; Barbacane RC; Felaco M; Grilli A; Placido FC; Reale M
    Immunol Lett; 1993 Jul; 37(1):1-6. PubMed ID: 8225402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking the interleukin-1 receptor inhibits leukotriene B4 and prostaglandin E2 generation in human monocyte cultures.
    Conti P; Panara MR; Barbacane RC; Placido FC; Bongrazio M; Reale M; Dempsey RA; Fiore S
    Cell Immunol; 1992 Nov; 145(1):199-209. PubMed ID: 1330330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 receptor antagonist inhibits calcium accumulation in in vivo chronic granuloma induced by potassium permanganate.
    Conti P; Reale M; Panara MR; Fridas S; Placido FC; Barbacane RC
    Calcif Tissue Int; 1993 Apr; 52(4):300-4. PubMed ID: 8385544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of leukotriene B4(LTB4) by recombinant interleukin-1 receptor antagonist (IL-1RA) on human monocytes.
    Conti P; Panara MR; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
    Agents Actions; 1992; Spec No():C93-5. PubMed ID: 1332453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
    Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
    Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human recombinant IL-1 receptor antagonist (IL-1Ra) inhibits leukotriene B4 generation from human monocyte suspensions stimulated by lipopolysaccharide (LPS).
    Conti P; Panara MR; Barbacane RC; Bongrazio M; Dempsey RA; Reale M
    Clin Exp Immunol; 1993 Mar; 91(3):526-31. PubMed ID: 8383025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
    McKenzie RC; Oran A; Dinarello CA; Sauder DN
    Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13.
    Deleuran B; Iversen L; Deleuran M; Yssel H; Kragballe K; Stengaard-Pedersen K; Thestrup-Pedersen K
    Cytokine; 1995 May; 7(4):319-24. PubMed ID: 8589261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia.
    Calkins CM; Bensard DD; Shames BD; Pulido EJ; Abraham E; Fernandez N; Meng X; Dinarello CA; McIntyre RC
    J Endotoxin Res; 2002; 8(1):59-67. PubMed ID: 11981446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C; Porter B; Fantuzzi G; Arend WP
    J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.
    Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P
    Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
    Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
    Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist.
    Cunha JM; Cunha FQ; Poole S; Ferreira SH
    Br J Pharmacol; 2000 Jul; 130(6):1418-24. PubMed ID: 10903985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inhibition of localized bone resorption by human recombinant interleukin-1 receptor antagonist.
    Chole RA; Faddis BT; Tinling SP
    J Bone Miner Res; 1995 Feb; 10(2):281-4. PubMed ID: 7754808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interleukin 1 receptor antagonist blocks the IL-1-induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma.
    Lu ZY; Bataille R; Poubelle P; Rapp MJ; Harousseau JL; Klein B
    Stem Cells; 1995 Aug; 13 Suppl 2():28-34. PubMed ID: 8520508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation.
    Ruth JH; Bienkowski M; Warmington KS; Lincoln PM; Kunkel SL; Chensue SW
    J Immunol; 1996 Apr; 156(7):2503-9. PubMed ID: 8786311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.
    Seckinger P; Klein-Nulend J; Alander C; Thompson RC; Dayer JM; Raisz LG
    J Immunol; 1990 Dec; 145(12):4181-4. PubMed ID: 2147937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
    Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages.
    Pue CA; Mortensen RF; Marsh CB; Pope HA; Wewers MD
    J Immunol; 1996 Feb; 156(4):1594-600. PubMed ID: 8568265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.